Dana-Farber’s Belfer Institute for Applied Cancer Science and Evotec Collaborate
Wednesday, May 01, 2013
Research collaboration aimed at discovering and commercialising novel cancer treatments based on epigenetic drug mechanisms.
Arrowhead Prices $36 Million Private Offering
Wednesday, May 01, 2013
Arrowhead Research Corporation announced that it has priced a private offering with gross proceeds expected to be $36 million. The offering was priced at $1.83 per common share.
Teva Expands Management Team
Wednesday, May 01, 2013
Teva Pharmaceutical Industries Ltd. announced that Paul J. Sekhri has been appointed Group Executive Vice President, Global Business Development and Chief Strategy Officer.
FORMA Therapeutics and Celgene Corporation Establish Broad Strategic Collaboration
Wednesday, May 01, 2013
FORMA and Celgene will discover, develop and commercialize drug candidates to regulate protein homeostasis targets.
Celator® Pharmaceuticals Raises $32.5 Million Completing a $39.3 Million Private Placement Financing
Wednesday, May 01, 2013
Proceeds will support phase 3 study of CPX-351 in acute myeloid leukemia.
Biologics Introduces Clinical Policy and Therapeutic Intelligence Office
Wednesday, May 01, 2013
Biologics is pleased to announce the launch of its Clinical Policy and Therapeutic Intelligence Office.
Sensile Medical Enters into an Agreement with scPharmaceuticals
Wednesday, May 01, 2013
The SenseCore technology offers opportunities for improved therapy outcomes and healthcare cost reduction.
OBT and Boehringer Ingelheim Enter Collaboration
Monday, April 29, 2013
Collaboration to discover novel antibody targets in cancer.
Genticel Secures EUR 18.2 Million (USD 23.7 million) in Capital Funding
Friday, April 26, 2013
Dr. Rainer Strohmenger joins the supervisory board of Genticel.
|
|
|
| << | 3 4 5 6 7 8 9 | >> | | Showing Results 51 - 60 of 2380 |
|
|
